Podcast Pearls
First-Generation TRK Inhibitors: Clinical Evidence and Indications

Podcast episode with expert insights on new data from SGO 2022 in endometrial, ovarian, and cervical cancers, from Clinical Care Options (CCO)

David Scott Miller, MD, FACOG, FACS Angeles Alvarez Secord, MD, MHSc Released: May 19, 2022

Interactive expert-led video on targeted therapies for glioblastoma, from Clinical Care Options (CCO)

Andrew B. Lassman, MD
Program Director Timothy Cloughesy, MD Rimas V. Lukas, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: May 19, 2022 Expired: May 18, 2023

Dr Yara Abdou discusses BRCA mutation testing and adjuvant therapy with olaparib in BRCA-mutated, HER2-negative early breast cancer, from Clinical Care Options (CCO)

Yara Abdou, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: May 17, 2022 Expired: May 16, 2023

Slideset from Dr Yara Abdou on adjuvant olaparib in BRCA1/2-mutated, HER2-negative early breast cancer, from Clinical Care Options (CCO)

Yara Abdou, MD Released: May 17, 2022